Page 10 - MemoriaBBN-Eng
P. 10




ORGANIZATION



The Permanent Commission is formed by the Vice-president of the Board of Trus- 

tees (General Deputy Director of Cooperative Research Networks and Centres), the 
Scientific Director, four committee members representing the consortium institutions, 

and the General Manager, acting as the Secretary. The Permanent Commission some- 

times meets to make those decisions which, given their nature, cannot wait to be ap- 
proved by the Board of Trustees. The Permanent Commission members in 2013 were:



• Instituto de Salud Carlos III. 

• Centro de Medicina Regenerativa de Barcelona. 

• Instituto de Bioingeniería de Cataluña. 


• Universidad de	Valencia. 

• Universidad de	Valladolid.



From the scientific point of view, the organisational structure is based on the member 
research groups, Research Programmes and Horizontal Programmes, with a coordina- 

tor for each Programme that is a Steering Committee member. Scientific decisions are 

made by the Scientific Director, counseled by the Steering Committee and the Scien- 
tific Advisory Board.

The Steering Committee, chaired by the Scientific Director comprises programme 

coordinators and the Managing Director.



STEERING COMMITTEE 2013

Position
Name

Scientific Director
Pablo Laguna Lasaosa
Steering 
Committee 
Assistant Scientific Director and Industrial Transfer Coordinator
Simó Schwartz Navarro
Members
Bioengineering Programme Coordinator
Jordi Aguiló Llobet

Biomaterials Programme Coordinator
José Luis Becerra Ratia

Nanomedicine Programme Coordinator
Ma. Pilar Marco Colás

Clinical Translation Coordinator
Margarita Calonge Cano

Platform Programme Coordinator
Jesús Santamaría Ramiro


Training Programme Coordinator
Javier Pavía Segura

Managing Director
Begoña Pérez Magallón


The members that are part of the CIBER-BBN Scientific Advisory Board are ten 

renowned scientists from the disciplines that the Centre works in. There are two re- 13
20
searchers in the Bioengineering Programme, three in the Biomaterials and Nanomedi- T 
cine Programmes, and two in the Horizontal Programmes.
R
PO
E
L R
A
NU
N
 A
 /
BN
B
R-
BE
CI


10






   8   9   10   11   12